AI medical concept stocks refer to publicly traded companies that apply artificial intelligence technology in healthcare. This sector utilizes advanced technologies like deep learning, natural language processing, and big data analytics for applications such as medical image recognition, diagnostic assistance, drug development, health management, and precision treatment.
- 1293.839
- -5.964-0.46%
U.S. stocks closed | Technology stocks stood out! The S&P experienced a thrilling three-day rise, with NVIDIA and Tesla both rising over 4%; Quantum Computing concept stock RGTI surged nearly 18%.
The Dow Jones has fallen for two consecutive days, while Tesla and AMD have risen by over 4%; the Chinese concept index has rebounded by over 1%, but JD.com has dropped by more than 4%, and U.S. bond yields have reached a one-month high.
10x Genomics Reaches Patent Litigation Settlement With Bruker; Bruker To Pay $68M In Equal Quarterly Installments Between Q3 2025 And Q2 2026 As Well As Ongoing Royalties On Sales Of Spatial Biology Products Through Life Of Licensed Patents
ABSI Stock Has Given up Its Prior Gain. Absci Shares Were Trading Higher After the Company Announced It Began Dosing the First Participants in Its Phase 1 ABS-101 Clinical Trial.
Express News | AI concept stocks in the U.S. market continue to rise, Super Micro Computer surged over 16%, AMD rose nearly 8%, and NVIDIA, Palantir, and Tempus AI increased over 3%.
Schrödinger To Present Phase 1 Clinical Data On MALT1 Inhibitor SGR-1505 At EHA Annual Congress And International Conference On Malignant Lymphoma
Beam Therapeutics To Present New Data From BEAM-101 Program II Sickle Cell Disease At European Hematology Association 2025 Congress
Jim Cramer: SoFi Goes To 'New Highs,' Recommends Not Buying This Health Care Stock
Boehringer Will Have Access To Tempus' De-identified Database Containing Molecular, Clinical, And Imaging Data And Its Analytical Platform, Lens As Part Of Collaboration
Assessing Absci: Insights From 6 Financial Analysts
Needham Reiterates Buy on Absci, Maintains $9 Price Target
Absci Analyst Ratings
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Express News | HIMS successfully raised 1 billion dollars, exceeding the original target by more than two times.
U.S. stock market close | Chip stocks supported the S&P to recover all declines this year, NVIDIA rose over 5%; Palantir surged over 8%, reaching a new all-time high.
Chip stocks led by Technology stocks supported the further rise of the two major U.S. stock indices, while the Medical insurance giant UnitedHealth suffered a heavy loss, dragging the other major index, the Dow, down.
12 Health Care Stocks Moving In Tuesday's After-Market Session
Hims & Hers Stock Soars 29% On Strong Q1 Earnings, Subscriber Growth
10x Genomics Analyst Ratings
Express News | U.S. stock AI Concept stocks surged, Tempus AI rose over 11%, Hims & HERS Health rose over 8%, Palantir rose over 4%, and AppLovin rose over 3%.
The USA will announce the selection list for the third round of drug price negotiations in February next year.
The USA Medical Insurance and Medical Assistance Services Center (CMS) plans to list up to 15 drugs selected for the third round of price negotiations before February 1, 2026, and is seeking public opinion.
Transforming into a 'stock god'? Trump has made two successful calls! The Nasdaq rebounded 20% and returned to a bull market. Who is leading the charge in this round?
The overall performance of the financial market seems as if Trump's "Liberation Day" tariff impact never occurred.